In the GBM patients who were stratified according to MGMT promoter methylation status, there was no significant association with HK3 expression, as shown in Fig. 4D. Moreover, we also validated these results using the CGGA datasets, and the results were shown in Figure S3. This evidence concerns the gene HK3 and glioblastoma.